FDA Gives Franko Herbal Centre 14 Days to Recall Herbal Mixture Over Undeclared Drugs

Ghana’s Food and Drugs Authority (FDA) has given Franko Herbal Centre 14 days to recall its Franko Herbal Mixture after laboratory tests detected undeclared diazepam and paracetamol in the product.

The directive follows concerns about the ingredients found in the herbal mixture, which could pose health risks to consumers who may not be aware that the product contains these substances.

According to the FDA, laboratory analysis detected diazepam and paracetamol in the mixture, although the substances were not declared as ingredients. The authority has therefore instructed the company to take action by recalling the affected product within the 14-day period.

Diazepam is a medicine commonly used to treat anxiety, muscle spasms and certain seizure-related conditions. It can cause drowsiness and may lead to dependence when used improperly. Paracetamol, on the other hand, is widely used to relieve pain and reduce fever. However, taking excessive amounts can cause serious liver damage.

The presence of these substances in an herbal preparation without proper declaration raises concerns about consumer safety. People who purchase herbal products may not expect them to contain conventional pharmaceutical medicines, making it difficult for them to make informed decisions about what they consume.

The FDA’s directive is intended to ensure that the affected product is removed from circulation and that consumers are protected from potential harm.

The authority has also urged members of the public to report any individual or business that continues to sell Franko Herbal Mixture after the recall directive. This appeal is aimed at helping officials identify sellers who may fail to comply with the order.

Consumers who have purchased the product are advised to pay attention to the FDA’s official announcements and follow its guidance regarding the recall. Anyone who experiences unusual symptoms after taking the mixture should seek medical advice.

The development serves as a reminder of the importance of regulatory checks on herbal medicines and other health products sold to the public. Although many people rely on herbal preparations for various health concerns, such products must meet the required safety and quality standards.

The FDA’s action also highlights the need for manufacturers to declare the ingredients in their products accurately so that consumers can understand what they are taking.

Franko Herbal Centre is expected to comply with the 14-day recall directive as the authority continues its efforts to protect public health and discourage the sale of products that may pose risks to consumers.

Writer_nana feedback-opera-news-app@opera.com